| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.38B | +11.0% |
| Cost of Revenue | $836.0M | +9.4% |
| Gross Profit | $2.54B | +11.6% |
| R&D Expense | $604.0M | -73.9% |
| SG&A Expense | $363.0M | -54.8% |
| Operating Income | $489.0M | +122.8% |
| Pre-tax Income | $552.0M | +126.8% |
| Income Tax | $95.0M | +121.6% |
| Net Income | $457.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.28B | -40.2% |
| Short-term Investments | $91.0M | +85.7% |
| Accounts Receivable | $1.01B | +18.9% |
| Current Assets | $2.70B | -18.4% |
| Total Assets | $4.12B | -12.9% |
| Current Liabilities | $798.0M | +8.9% |
| Total Liabilities | $836.0M | +4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $687.0M | +17.2% |
| Capital Expenditures | $64.0M | +18.5% |
| Investing Cash Flow | -$107.0M | -179.3% |
| Financing Cash Flow | -$1.41B | -4610.0% |
| Free Cash Flow | $623.0M | +17.1% |
| +128.2% |
| EPS (Basic) | $1.69 | +113.6% |
| EPS (Diluted) | $1.58 | +112.7% |
| Stockholders' Equity |
| $3.09B |
| -17.5% |